Tetrahedron Letters
Catalyst controlled regioselective Suzuki cross-coupling
of 2-(4-bromophenyl)-5-chloropyrazine
⇑
⇑
Christopher P. Ashcroft , Steven J. Fussell , Katie Wilford
Pfizer, Chemical Research & Development, Sandwich Laboratories, Sandwich CT13 9NJ, UK
a r t i c l e i n f o
a b s t r a c t
Article history:
The Suzuki cross-coupling between 2-(4-bromophenyl)-5-chloropyrazine and a range of aryl boronic
acids has been investigated. The regioselectivity of the reaction can be switched between the aryl bro-
mide and pyrazinyl chloride positions by changing the ligand associated with the palladium catalyst.
Xantphos has shown excellent selectivity for the pyrazinyl chloride, with most other ligands showing
preferential selectivity for the aryl bromide.
Received 16 April 2013
Revised 3 June 2013
Accepted 14 June 2013
Available online 24 June 2013
Ó 2013 Elsevier Ltd. All rights reserved.
Keywords:
Suzuki
Chemoselectivity
Pyrazine
Xantphos
Boronate
The palladium-catalysed cross-coupling reaction of organobo-
ron compounds with organic halides and triflates (the Suzuki–
Miyaura reaction), is one of the most widely used reactions for
the formation of carbon–carbon bonds. First published by Akira Su-
zuki in 1979, the reaction is firmly established within the pharma-
ceutical industry as the method of choice for the preparation of
biaryl compounds.1 Whilst chemoselective discrimination between
halides and pseudohalides is relatively common in the Suzuki–
Miyaura literature,2,3 examples where the site of reactivity can
be efficiently switched by changing the ligand, are much rarer.
Herein we report the results of the chemoselective Suzuki–Miya-
ura cross coupling reaction between 2-(4-bromophenyl)-5-chloro-
pyrazine and a range of boronic esters and acids. The position of
reaction can be efficiently discriminated between the bromophe-
nyl and chloropyrazinyl sites by simply changing the ligand.
During the course of alternative route investigations for a series
of antiviral targets, the synthesis of a key triaryl intermediate 3
was required. It was hoped that 3 could be accessed via a chemo-
selective Suzuki–Miyaura cross-coupling between 2-(4-bromophe-
nyl)-5-chloropyrazine (1) and the benzimidazole boronic ester 2
(Scheme 1). As an initial starting point, two catalyst systems which
had given good results on related substrates were investigated
namely Pd(dppf)Cl 2ÁDCM and Pd(t-Bu3P)2.
switched to 1:20, again with appreciable levels of over-reaction
impurity 5. These somewhat surprising results prompted us to fur-
ther investigate this coupling reaction.
A preliminary investigation of the Suzuki–Miyaura coupling of 1
with 2 was initiated by examining a variety of pre-ligated palla-
dium catalysts supplied by Johnson Matthey. The aim was to afford
3 in high yields whilst minimising 4 and the over-reaction impu-
rity 5. Several bases and solvents were also studied and the results
are summarised in Table 1. Whereas high conversions (>65%) to 4
were generally observed with most electron-rich catalysts, entries
5–10, gratifyingly, high conversion into desired compound 3, with
negligible formation of regioisomer 4 or over reaction product 5,
was obtained using the wide bite angle or trans-spanning diphos-
phine, Pd(Xantphos)Cl2 with Na2CO3 as the base and 1,4-dioxane
as the solvent (entry 1). Compared with Pd(dtbpf)Cl2, entry 8, the
reaction goes with a complete switch in reactivity from the aryl
bromide to the chloropyrazine tail. Interestingly both Pd(dppf)Cl2
and Pd(PPh3)4 showed encouraging chemoselectively for the chlo-
ropyrazine, but suffered over-reaction to 5. However, the screening
data illustrated that the only catalyst to give high chemoselectivity
for the chloropyrazine position was in fact Pd(Xantphos)Cl2.
N
The regioselectivity observed for these two systems was
intriguing. Using Pd(dppf)Cl2ÁDCM, the ratio of products was 9:1
favouring regioisomer 3 over 4, with an appreciable amount of
the over-reaction impurity, 5. However, with Pd(t-Bu3P)2, the ratio
N
N
H
N
Boc
N
N
N
Boc
N
H
⇑
Corresponding authors. Tel.: +44 (0)1304646782; fax: +44 (0)1304652318.
5
0040-4039/$ - see front matter Ó 2013 Elsevier Ltd. All rights reserved.